It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
We recently found headache disorders to be highly prevalent among children (aged 6–11 years) and adolescents (aged 12–17) in Iran (gender- and age-adjusted 1-year prevalences: migraine 25.2%, tension-type headache 12.7%, undifferentiated headache [UdH] 22.1%, probable medication-overuse headache [pMOH] 1.1%, other headache on ≥ 15 days/month [H15+] 3.0%). Here we report on the headache-attributed burden, taking evidence from the same study.
Methods
In a cross-sectional survey, following the generic protocol for the global schools-based study led by the Global Campaign against Headache, we administered the child and adolescent versions of the Headache-Attributed Restriction, Disability, Social Handicap and Impaired Participation (HARDSHIP) structured questionnaire in 121 schools, purposively selected to reflect the country’s diversities. Pupils self-completed these in class, under supervision. Headache diagnostic questions were based on ICHD-3 criteria but for the inclusion of UdH (defined as mild headache with usual duration < 1 h). Burden enquiry was across multiple domains.
Results
The analysed sample (N = 3,244) included 1,308 (40.3%) children and 1,936 (59.7%) adolescents (1,531 [47.2%] male, 1,713 [52.8%] female). The non-participating proportion was 3.4%. Mean headache frequency was 3.9 days/4 weeks, and mean duration 1.8 h. Estimated mean proportion of time in ictal state was 1.1% (1.4% for migraine, 16.5% for pMOH). Symptomatic medication was consumed on a mean of 1.6 days/4 weeks. Lost school time averaged 0.4 days/4 weeks overall (2%, assuming a 5-day week), but was eleven-fold higher (4.3 days; 22%) for pMOH. For most headache types, days of reported limited activity were several-fold more than days lost from school (45% for pMOH, 25% for other H15+). Almost one in 12 parents (7.9%) missed work at least once in 4 weeks because of their son’s or daughter’s headache. Emotional impact and quality-of-life scores reflected these measures of burden.
Conclusions
Headache, common in children and adolescents in Iran, is associated with symptom burdens that may be onerous for some but not for most. However, there are substantial consequential burdens, particularly for the 1.1% with pMOH and the 3.0% with other H15+, who suffer educational disturbances and potentially major life impairments. These findings are of importance to educational and health policies in Iran.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Tehran University of Medical Sciences, Headache Department, Iranian Center of Neurological Researches, Institute of Neuroscience, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922); Sina Hospital, Tehran University of Medical Sciences, Neurology Ward, School of Medicine, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922)
2 National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, Tehran, Iran (GRID:grid.411600.2)
3 University of New South Wales (UNSW), The George Institute for Global Health, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
4 Ahvaz Jundishappur University of Medical Sciences, Department of Neurology, School of Medicine, Ahvaz, Iran (GRID:grid.411230.5) (ISNI:0000 0000 9296 6873)
5 Tehran University of Medical Sciences, Headache Department, Iranian Center of Neurological Researches, Institute of Neuroscience, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922)
6 Golestan University of Medical Sciences, Neonatal and Children’s Health Research Center, Gorgan, Iran (GRID:grid.411747.0) (ISNI:0000 0004 0418 0096); Golestan University of Medical Sciences, Pediatric Neurology Department, Faculty of Medicine, Gorgan, Iran (GRID:grid.411747.0) (ISNI:0000 0004 0418 0096)
7 Mersin University School of Medicine, Department of Public Health, Mersin, Turkey (GRID:grid.411691.a) (ISNI:0000 0001 0694 8546)
8 Istanbul University, Neurology Department, Cerrahpaşa School of Medicine, Istanbul, Turkey (GRID:grid.9601.e) (ISNI:0000 0001 2166 6619)
9 Norwegian University of Science and Technology, Department of Neuromedicine and Movement Science, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393); University of Copenhagen, Department of Neurology, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Imperial College London, Division of Brain Sciences, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)